US News & World Report: Lung cancer screening and COVID-19
December 21, 2020
New UC research shows a dangerous trend in lung cancer caused by the pandemic.
December 21, 2020
New UC research shows a dangerous trend in lung cancer caused by the pandemic.
February 2, 2022
The University of Cincinnati's Chad Zender is leading a clinical trial studying if using a combination of Cesium-131 radioactive seeds and immunotherapy can be more effective and provide better quality of life than current treatments for patients with recurrent head and neck cancer.
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
January 5, 2021
Drugs.com reports that COVID-19 has caused significant disruption in lung cancer screening.
January 21, 2021
UC research, published in JAMA Oncology, shows that chemotherapy before surgery for some pancreatic cancer patients may not improve survival rates.
February 6, 2024
A new University of Cincinnati trial, in partnership with Spark Biomedical, will test a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.
April 6, 2021
UC researchers are opening a national clinical trial to see if a therapy that has shown promise in treating lung and uterine cancer could be applied to pancreatic cancer, too.
March 31, 2021
A new study reveals that an evidence-based treatment may help predict treatment outcomes for adolescents with anxiety disorders. University of Cincinnati researchers say this could determine medication effectiveness more quickly to help patients.
February 17, 2021
A researcher at the University of Cincinnati is studying whether electrical stimulation of the spinal cord can be helpful in treating certain psychiatric conditions, like depression.